223 related articles for article (PubMed ID: 6114171)
1. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
[TBL] [Abstract][Full Text] [Related]
2. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
3. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
Baum T; Sybertz EJ
Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
[TBL] [Abstract][Full Text] [Related]
6. Cardiac electrophysiologic actions of SCH 19927 (Dilevalol), the R,R-isomer of labetalol.
Lynch JJ; Montgomery DG; Lucchesi BR
J Pharmacol Exp Ther; 1986 Dec; 239(3):719-23. PubMed ID: 3795037
[TBL] [Abstract][Full Text] [Related]
7. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological effects of labetalol in man.
Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
Uchida W; Shibasaki K; Asano M; Takenaka T
Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704
[TBL] [Abstract][Full Text] [Related]
10. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
Lammintausta R; Koulu M; Allonen H
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
Saito D; Abe Y; Tani H; Kusachi S; Takeda K; Hyodo T; Haraoka S; Nagashima H
Arzneimittelforschung; 1986; 36(1):88-91. PubMed ID: 2869764
[TBL] [Abstract][Full Text] [Related]
12. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological properties of (+/-)-4-[2-hydroxy-3-(3-(2-methoxyphenoxy)-2-propylamino)propoxy]-1(2H) -isoquinolinone (N-1518), a new combined alpha- and beta-adrenoceptor blocking drug].
Sugai T
Nihon Yakurigaku Zasshi; 1990 Sep; 96(3):117-27. PubMed ID: 1980255
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Pandhi P; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
[TBL] [Abstract][Full Text] [Related]
15. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Riva E; Mennini T; Latini R
Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
[TBL] [Abstract][Full Text] [Related]
16. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
Kennedy I; Levy GP
Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
[TBL] [Abstract][Full Text] [Related]
17. [Effects of labetalol on the circulatory system (author's transl)].
Monma Y; Okuoka Y; Kameda H; Ichihara K; Abiko Y; Tanabe T
Nihon Yakurigaku Zasshi; 1980 May; 76(4):239-54. PubMed ID: 6108907
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalol.
Gold EH; Chang W; Cohen M; Baum T; Ehrreich S; Johnson G; Prioli N; Sybertz EJ
J Med Chem; 1982 Nov; 25(11):1363-70. PubMed ID: 6128421
[TBL] [Abstract][Full Text] [Related]
19. Hypotensive effect of labetalol on intraocular pressure in rabbits: in relation to its alpha- and beta-adrenergic blocking action on the cardiovascular system.
Kogure H; Hosaka A; Abiko Y
Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):109-22. PubMed ID: 6268004
[TBL] [Abstract][Full Text] [Related]
20. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
Honda K; Takenaka T; Miyata-Osawa A; Terai M
J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
